Fulgent Genetics

From Verify.Wiki
Jump to: navigation, search
Fulgent Genetics
Type Public
Industry Biotechnology
Founded 2011
Headquarters Temple City, California 91780 United States
Key people Ming Hsieh (CEO), Han Lin Gao ( Chief Scientific Officer), Paul Kim (CFO) Cite error: Closing </ref> missing for <ref> tag

Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics. It focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016.
They have Accreditations from the following:

  • Clinical Laboratory Improvement Amendments (CLIA) License 2015-2017
  • College of American Pathologists (CAP) Accreditation 2017
  • California Clinical Laboratory License 2016
  • Florida Clinical Laboratory License 2016 - 2018
  • Pennsylvania Clinical Laboratory Permit 2016-2017
  • Maryland Medical Laboratory License 2015-2016



Top 5 Recent Tweets

December 12, 2018stocknewstimesAeon Global Health (AGHC) versus Fulgent Genetics (FLGT) Financial Review https://t.co/Wif6xq0Y2d
December 09, 2018dailypoliticalnAnalyzing Psychemedics $PMD &amp; Fulgent Genetics $FLGT https://t.co/UQ4wMfP0GH
December 08, 2018mmahotstuff1Can Fulgent Genetics Inc $FLGT’s Tomorrow Be Different? The Stock Had Decline in Shorts - https://t.co/wsDaMRFEj9

Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history